CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- ScaleMarket cap is $6.89B, above the global median of $1.18B
- PositionReturn on assets is 7.8%, higher than 95% of its Pharmaceutical Retailers peers (median 3.9%)
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.35%Above 5Y avg (1.22%)
Annual Rate
BRL 0.46Paid quarterly
Payout Ratio
51.9%Sustainable
Payback Period
40.2 yr
Last Ex-Dividend
Jul 6, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
35.37BBRL6.89B · vs all stocks (USD)
Trailing P/E
24.25xvs Pharmaceutical Retailers peers
Revenue (TTM)
46.53BBRL9.06B · vs all stocks (USD)
Profit Margin
2.89%vs Pharmaceutical Retailers peers
Beta
0.0230xvs all stocks
52-Week Change
10.15%vs all stocks
Forward Annual Dividend Yield
2.35%vs all stocks
Market Capitalization
35.37BBRL6.89B · vs all stocks (USD)
Enterprise Value
43.98BBRL8.56B · vs all stocks (USD)
Trailing P/E
24.25xvs Pharmaceutical Retailers peers
Forward P/E
17.61xvs Pharmaceutical Retailers peers
PEG Ratio
1.54xPrice to Sales (TTM)
0.7744xvs Pharmaceutical Retailers peers
Price to Book (MRQ)
4.94xvs Pharmaceutical Retailers peers
Enterprise to Revenue
0.9450xvs Pharmaceutical Retailers peers
Enterprise to EBITDA
11.39xvs Pharmaceutical Retailers peers
Gross Margin
33.43%vs Pharmaceutical Retailers peers
Profit Margin
2.89%vs Pharmaceutical Retailers peers
Operating Margin
7.58%vs Pharmaceutical Retailers peers
Return on Assets (TTM)
7.80%vs Pharmaceutical Retailers peers
Return on Equity (TTM)
19.99%vs Pharmaceutical Retailers peers
Revenue (TTM)
46.53BBRL9.06B · vs all stocks (USD)
Revenue per Share (TTM)
28.53BRLUpdated Sep 23, 2026Quarterly Revenue Growth
9.80%vs Pharmaceutical Retailers peers
Gross Profit (TTM)
14.10BBRL2.74B · vs all stocks (USD)
EBITDA (TTM)
4.31BBRL838.95M · vs all stocks (USD)
Net Income (TTM)
1.40BBRL273.29M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
13.50%vs Pharmaceutical Retailers peers
Operating Cash Flow (TTM)
3.02BBRL588.22M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
2.18BBRL424.56M · vs all stocks (USD)
Forward Annual Dividend Rate
0.4623BRLUpdated Sep 23, 2026Forward Annual Dividend Yield
2.35%vs all stocks
Trailing Annual Dividend Rate
0.4397BRLUpdated Sep 23, 2026Trailing Annual Dividend Yield
2.23%vs all stocks
5-Year Average Dividend Yield
1.22%vs all stocks
Payout Ratio
51.86%vs Pharmaceutical Retailers peers
Minority Interest (Equity)
13.84MBRLFY2025 · Dec 31, 2025Revenue
44.25BBRLFY2025 · Dec 31, 2025Cost of Goods Sold
31.29BBRLFY2025 · Dec 31, 2025Gross Profit
12.96BBRLFY2025 · Dec 31, 2025Operating Income
2.65BBRL515.65M · vs all stocks (USD)
Pre-tax Income
1.45BBRLFY2025 · Dec 31, 2025Income Tax Expense
147.81MBRLFY2025 · Dec 31, 2025Net Income
1.30BBRLFY2025 · Dec 31, 2025EBIT
2.51BBRLFY2025 · Dec 31, 2025EBITDA (Income Statement)
3.46BBRLFY2025 · Dec 31, 2025Selling, General & Administrative
10.29BBRLFY2025 · Dec 31, 2025Other Operating Expenses
28.11MBRLFY2025 · Dec 31, 2025Non-operating Interest Income
0.00BRLFY2025 · Dec 31, 2025Non-operating Interest Expense
1.07BBRLFY2025 · Dec 31, 2025EPS (Basic)
0.7874BRLFY2025 · Dec 31, 2025EPS (Diluted)
0.7820BRLFY2025 · Dec 31, 2025Basic Shares Outstanding
1.65BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.65BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
1.36BBRLFY2025 · Dec 31, 2025Minority Interests (P&L)
-3.38MBRLFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00BRLFY2025 · Dec 31, 2025Operating Cash Flow
-77.11MBRLFY2025 · Dec 31, 2025Free Cash Flow
-1.48BBRLFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
509.62MBRLFY2025 · Dec 31, 2025Starting Profit (CF Statement)
1.36BBRLFY2025 · Dec 31, 2025Stock-based Compensation
27.98MBRLFY2025 · Dec 31, 2025Other Non-cash Items
537.25MBRLFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-754.23MBRLFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-1.25BBRLFY2025 · Dec 31, 2025Capital Expenditures
-1.40BBRLFY2025 · Dec 31, 2025Net Acquisitions
0.00BRLFY2025 · Dec 31, 2025Other Investing Activity
-3.41MBRLFY2025 · Dec 31, 2025Net Investing Cash Flow
-1.41BBRLFY2025 · Dec 31, 2025Long-term Debt Issuance
1.19BBRLFY2025 · Dec 31, 2025Long-term Debt Payments
-653.87MBRLFY2025 · Dec 31, 2025Common Stock Repurchase
0.00BRLFY2025 · Dec 31, 2025Other Financing Charges
-5.48MBRLFY2025 · Dec 31, 2025Net Financing Cash Flow
530.65MBRLFY2025 · Dec 31, 2025Shares Outstanding
1.75BSharesUpdated Sep 23, 2026Float Shares
1.31BSharesUpdated Sep 23, 2026% Held by Insiders
25.27%vs all stocks
% Held by Institutions
58.37%vs all stocks
Total Cash (MRQ)
652.95MBRL127.10M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.3730BRLUpdated Sep 23, 2026Total Debt (MRQ)
8.59BBRL1.67B · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.18xvs Pharmaceutical Retailers peers
Current Ratio (MRQ)
1.41xvs Pharmaceutical Retailers peers
Book Value per Share (MRQ)
4.17BRLUpdated Sep 23, 2026Total Assets
25.17BBRL4.90B · vs all stocks (USD)
Total Current Assets
14.90BBRLFY2025 · Dec 31, 2025Total Liabilities
17.83BBRLFY2025 · Dec 31, 2025Total Non-current Assets
10.27BBRLFY2025 · Dec 31, 2025Total Non-current Liabilities
7.64BBRLFY2025 · Dec 31, 2025Total Current Liabilities
10.19BBRLFY2025 · Dec 31, 2025Cash
222.23MBRLFY2025 · Dec 31, 2025Cash Equivalents
287.39MBRLFY2025 · Dec 31, 2025Cash & Cash Equivalents
509.62MBRLFY2025 · Dec 31, 2025Other Short-term Investments
19.12MBRLFY2025 · Dec 31, 2025Accounts Receivable
3.40BBRLFY2025 · Dec 31, 2025Inventory
9.58BBRLFY2025 · Dec 31, 2025Accounts Payable
6.91BBRLFY2025 · Dec 31, 2025Short-term Debt
1.53BBRLFY2025 · Dec 31, 2025Other Current Liabilities
482.50MBRLFY2025 · Dec 31, 2025Long-term Debt
7.30BBRLFY2025 · Dec 31, 2025Other Non-current Liabilities
71.45MBRLFY2025 · Dec 31, 2025Common Stock (Book)
4.75BBRLFY2025 · Dec 31, 2025Retained Earnings
0.00BRLFY2025 · Dec 31, 2025Total Shareholders' Equity
7.34BBRL1.43B · vs all stocks (USD)
Treasury Stock
104.08MBRLFY2025 · Dec 31, 202552-Week Low
16.21BRLUpdated Sep 23, 202652-Week High
27.42BRLUpdated Sep 23, 202652-Week Change
10.15%vs all stocks
Beta
0.0230xvs all stocks
50-Day MA
18.97BRLUpdated Sep 23, 2026200-Day MA
21.34BRLUpdated Sep 23, 2026Avg 10-Day Volume
8.26MSharesUpdated Sep 23, 2026Avg 30-Day Volume
9.06MSharesUpdated Sep 23, 2026Diluted EPS (TTM)
0.8500BRLUpdated Sep 23, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Return on assets is 7.8%, higher than 95% of its Pharmaceutical Retailers peers (median 3.9%)Significant
Return on assets: 0.08Industry median: 0.04Industry P95: 0.08Peers compared: 29.00
Price-to-book is 4.94×, higher than 95% of its Pharmaceutical Retailers peers (median 2.18×)Significant
Price-to-book: 4.94Industry median: 2.18Industry P95: 4.49Peers compared: 29.00
Financial Health
Altman Z-Score 3.5: safe zoneNotable
Altman Z-Score: 3.50
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Scale
Market cap is $6.89B, above the global median of $1.18BNotable
Market cap (USD): 6,885,686,392.485Global Median: 1,180,223,658.953
Revenue is $9.06B, above the global median of $548.88MNotable
Revenue (USD): 9,058,279,063.47Global Median: 548,883,780.48
Levered free cash flow is $424.56M, above the global median of $18.73MNotable
Levered free cash flow (USD): 424,564,360.96Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Lithia Motors Inc.
Tier 1FlowUnit ReplicationInterfaceRisk
President Chain Store Corporation
Tier 1FlowUnit ReplicationInterfaceProduction
Rush Enterprises Inc.
Tier 1FlowUnit ReplicationInterfaceRisk
Kingfisher plc
Tier 1FlowUnit ReplicationProductionInterface
Victoria's Secret & Co.
Tier 1FlowUnit ReplicationRiskInterface
Gap Inc.
Tier 1FlowUnit ReplicationRiskInterface
The Gap, Inc.
Tier 1FlowUnit ReplicationRiskInterface
Bbb Foods Inc.
Tier 1FlowUnit ReplicationProductionInterface
CarMax Inc.
Tier 1FlowUnit ReplicationInterfaceRisk
Sprouts Farmers Market Inc.
Tier 1FlowUnit ReplicationInterfaceProduction
Companies that share active interpretations — structural patterns currently present in both stocks.
Ningbo Deye Technology Co., Ltd.
2 interpretationsIndustry-Benchmarked ROA and Margin ElevatedMulti-Year Revenue, Profit, And Income Growth
Shandong Bailong Chuangyuan Biotechnology Co. Ltd.
2 interpretationsIndustry-Benchmarked ROA and Margin ElevatedMulti-Year Revenue, Profit, And Income Growth
Shanghai Action Education Technology Co., Ltd.
2 interpretationsIndustry-Benchmarked ROA and Margin ElevatedMulti-Year Revenue, Profit, And Income Growth